Loading page…

Report overview

The report describes ROVI's 2016 growth, including total revenue of 266.7 million euros and strong prescription-pharmaceutical performance. It reports 1,150 employees at year-end and extensive workforce training. Environmental disclosures include 9,926.38 tonnes of CO2 emissions and 2,810.67 tonnes of waste generated. CSR decisions are assigned to the Board of Directors, while the report follows the IIRC framework and references GRI G4 for non-financial information.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2016
Period: 1 January 2016 – 31 December 2016
Language
Pages
File size

Standards & Assurance

No standards or assurance data is available for this report.

ESG & Materiality

ESG data

Indicators available in this report:

Waste
Employees
Women in management

No materiality data is available for this report.

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services